Cargando…

The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements

The common IVSI-110 (G>A) β-thalassemia mutation is a paradigm for intronic disease-causing mutations and their functional repair by non-homologous end joining-mediated disruption. Such mutation-specific repair by disruption of aberrant regulatory elements (DARE) is highly efficient, but to date,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patsali, Petros, Mussolino, Claudio, Ladas, Petros, Floga, Argyro, Kolnagou, Annita, Christou, Soteroula, Sitarou, Maria, Antoniou, Michael N., Cathomen, Toni, Lederer, Carsten Werner, Kleanthous, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912506/ https://www.ncbi.nlm.nih.gov/pubmed/31766235 http://dx.doi.org/10.3390/jcm8111959

Ejemplares similares

Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBB(IVSI−110 (G > A)) β-Thalassemia
por: Patsali, Petros, et al.
Publicado: (2020)

Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus
por: Kountouris, Petros, et al.
Publicado: (2020)

High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis
por: Papaioannou, Nikoletta Y., et al.
Publicado: (2023)

Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
por: Patsali, Petros, et al.
Publicado: (2019)

Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells
por: Papasavva, Panayiota L., et al.
Publicado: (2021)

A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β‐thalassemia major
por: Fanis, Pavlos, et al.
Publicado: (2019)

Sex-specific transcriptional profiles identified in β-thalassemia patients
por: Nanou, Aikaterini, et al.
Publicado: (2021)

Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies
por: Loucari, Constantinos C., et al.
Publicado: (2018)

The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study
por: Kountouris, Petros, et al.
Publicado: (2016)

CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation
por: Papasavva, Panayiota L., et al.
Publicado: (2022)

Measurement of lentiviral vector titre and copy number by cross-species duplex quantitative PCR
por: Christodoulou, I, et al.
Publicado: (2016)

Recent trends in the gene therapy of β-thalassemia
por: Finotti, Alessia, et al.
Publicado: (2015)

Allele-Specific Disruption of a Common STAT3 Autosomal Dominant Allele Is Not Sufficient to Restore Downstream Signaling in Patient-Derived T Cells
por: König, Saskia, et al.
Publicado: (2022)

Chimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors
por: Fang, Yongxing, et al.
Publicado: (2020)

IthaGenes: An Interactive Database for Haemoglobin Variations and Epidemiology
por: Kountouris, Petros, et al.
Publicado: (2014)

Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases
por: Bloom, Kristie, et al.
Publicado: (2013)

Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients
por: Aushev, Magomet, et al.
Publicado: (2017)

Transfusion-Related Acute Lung Injury (TRALI) in two Thalassaemia Patients Caused by the Same Multiparous Blood Donor
por: Kolnagou, Annita, et al.
Publicado: (2017)

Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology
por: Kontoghiorghe, Christina N., et al.
Publicado: (2015)

A Retrospective Long-Term Study on Age at Menarche and Menstrual Characteristics in 85 Young Women with Transfusion-Dependent β-Thalassemia (TDT)
por: Di Maio, Salvatore, et al.
Publicado: (2021)

A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity
por: Mussolino, Claudio, et al.
Publicado: (2011)

TALEN-mediated functional correction of human iPSC-derived macrophages in context of hereditary pulmonary alveolar proteinosis
por: Kuhn, Alexandra, et al.
Publicado: (2017)

Genome Editing of the SNAI1 Gene in Rhabdomyosarcoma: A Novel Model for Studies of Its Role
por: Ulman, Aleksandra, et al.
Publicado: (2020)

Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA
por: Bloom, Kristie, et al.
Publicado: (2019)

Conventional and Unconventional Approaches for Innovative Drug Treatments in COVID-19: Looking Outside of Plato’s Cave
por: Kontoghiorghes, George J., et al.
Publicado: (2021)

Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model
por: Alzubi, Jamal, et al.
Publicado: (2017)

New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications
por: Kontoghiorghes, George J., et al.
Publicado: (2021)

Editorial: Insights in thalassemia: from genomics to clinical practice
por: Silao, Catherine Lynn T., et al.
Publicado: (2023)

2'-O-methoxyethyl splice-switching oligos correct splicing from IVS2-745 β-thalassemia patient cells restoring hemoglobin A production and chain rebalance
por: Dong, Alisa, et al.
Publicado: (2020)

TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity
por: Mussolino, Claudio, et al.
Publicado: (2014)

Marital status and paternity in patients with Transfusion-Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries
por: De Sanctis, Vincenzo, et al.
Publicado: (2019)

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
por: Papasavva, Panayiota, et al.
Publicado: (2019)

Therapy Development by Genome Editing of Hematopoietic Stem Cells
por: Koniali, Lola, et al.
Publicado: (2021)

β-Thalassemia and ocular implications: a systematic review
por: Liaska, Aliki, et al.
Publicado: (2016)

Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications
por: Kontoghiorghes, George J., et al.
Publicado: (2020)

A Multicenter ICET-A Study on Age at Menarche and Menstrual Cycles in Patients with Transfusion-Dependent Thalassemia (TDT) who Started Early Chelation Therapy with Different Chelating Agents
por: Di Maio, Salvatore, et al.
Publicado: (2023)

Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells
por: Mlambo, Tafadzwa, et al.
Publicado: (2018)

Shaping the nasal tip: A new approach to transdomal suturing
por: Kypraiou, Argyro, et al.
Publicado: (2018)

Simultaneous measurements of foveal and peripheral aberrations with accommodation in myopic and emmetropic eyes
por: Romashchenko, Dmitry, et al.
Publicado: (2021)

Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells
por: Holkers, Maarten, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p3f39i73uhvejuk0gn32p8hfna